Home/Filings/4/0001209191-23-036289
4//SEC Filing

Ward Anne Sempowski 4

Accession 0001209191-23-036289

CIK 0001347178other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 4:20 PM ET

Size

7.4 KB

Accession

0001209191-23-036289

Insider Transaction Report

Form 4
Period: 2023-06-08
Transactions
  • Award

    Common Stock

    2023-06-08+17,30739,313 total
  • Award

    Stock Option (right to buy)

    2023-06-08+33,96033,960 total
    Exercise: $6.50Exp: 2033-06-07Common Stock (33,960 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
  • [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001790117

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:20 PM ET
Size
7.4 KB